pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 15·1 min read
save

AC Immune CEO Andrea Pfeifer Retires After 23 Years, Company Begins CEO Search

May 15, 2026·read at Endpoints ↗Neutral

AC Immune announced that its chief executive Andrea Pfeifer will step down after a 23‑year tenure.

Pfeifer, who has guided the biotech through multiple development programs, said she will retire and will assist with the transition.

The board said a search for a new CEO will begin immediately, marking the first time the company will appoint a leader from outside the current executive team.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Andrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement”

read at Endpoints ↗
90 words · retrieved May 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AC Immune SA3
topics
Immunology3

related stories

  • Oct 7Cerevance Parkinson’s drug shortens 'off time' in Ph. 3, paving path to FDABioSpace
  • Sep 28AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeoverBioSpace
  • Sep 8Reeling from past failures, Parkinson's pipeline enters 'era of diversification'BioSpace
  • Aug 20Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trialEndpoints
  • May 13Assertio accepts new buyout bid; AI biotech Isomorphic banks $2BBioPharma Dive